ACA
PROF

AYAL Capital Advisors’s Profound Medical PROF Stock Holding History

AYAL Capital Advisors’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-41,308
Closed -$244K – 64
2025
Q2 		$244K Sell
41,308
-8,692
-17% -$46K 0.06% 52
2025
Q1 		$291K Hold
50,000
– – 0.1% 43
2024
Q4 		$376K Buy
+50,000
New +$384K 0.1% 43

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RMC
Ring Mountain Capital Tiburon, California $183M AUM 38.9% 1-Year Est. Return

AYAL Capital Advisors's PROF Position: Q3 2025 in Review

AYAL Capital Advisors sold out of Profound Medical (PROF) in Q3 2025, closing a stake of 41,308 shares — an estimated $244K sold.

AYAL Capital Advisors first reported a position in PROF in Q4 2024 and held it in 3 quarters. The position peaked at $376K in Q4 2024. 43 funds tracked by Wall St. Rank hold PROF as of Q3 2025.

  • AYAL Capital Advisors reported no remaining Profound Medical position as of Q3 2025 after selling out during the quarter.
  • AYAL Capital Advisors sold 41,308 Profound Medical shares in Q3 2025, an estimated $244K.
  • AYAL Capital Advisors first reported a position in Profound Medical in Q4 2024 and held it in 3 quarters.
  • AYAL Capital Advisors's Profound Medical position peaked at $376K in Q4 2024.
  • 43 funds tracked by Wall St. Rank held Profound Medical as of Q3 2025.

Based on AYAL Capital Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.